Free Trial

Bryce Point Capital LLC Makes New Investment in Novanta Inc. (NASDAQ:NOVT)

Novanta logo with Computer and Technology background
Remove Ads

Bryce Point Capital LLC purchased a new position in Novanta Inc. (NASDAQ:NOVT - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 11,981 shares of the technology company's stock, valued at approximately $1,830,000. Novanta makes up 0.5% of Bryce Point Capital LLC's holdings, making the stock its 21st largest holding.

Other institutional investors and hedge funds have also bought and sold shares of the company. FMR LLC grew its holdings in Novanta by 127.0% during the 3rd quarter. FMR LLC now owns 8,025 shares of the technology company's stock valued at $1,436,000 after buying an additional 4,489 shares in the last quarter. BNP Paribas Financial Markets grew its stake in Novanta by 34.7% during the third quarter. BNP Paribas Financial Markets now owns 20,054 shares of the technology company's stock valued at $3,588,000 after acquiring an additional 5,165 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank increased its holdings in Novanta by 3.2% in the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 8,147 shares of the technology company's stock valued at $1,458,000 after acquiring an additional 249 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in Novanta by 110.2% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 100,259 shares of the technology company's stock worth $17,938,000 after purchasing an additional 52,573 shares in the last quarter. Finally, HighTower Advisors LLC bought a new position in shares of Novanta during the 3rd quarter valued at about $257,000. 98.35% of the stock is owned by institutional investors.

Remove Ads

Novanta Price Performance

Shares of NOVT traded down $2.32 during mid-day trading on Monday, hitting $101.81. 339,507 shares of the stock were exchanged, compared to its average volume of 181,933. The company has a debt-to-equity ratio of 0.61, a quick ratio of 1.81 and a current ratio of 2.79. The company has a market cap of $3.66 billion, a PE ratio of 61.12 and a beta of 1.42. Novanta Inc. has a 52-week low of $98.71 and a 52-week high of $187.12. The firm has a 50-day moving average of $139.98 and a two-hundred day moving average of $156.79.

Novanta (NASDAQ:NOVT - Get Free Report) last released its quarterly earnings data on Tuesday, February 25th. The technology company reported $0.76 EPS for the quarter, beating the consensus estimate of $0.71 by $0.05. The business had revenue of $238.10 million during the quarter, compared to analyst estimates of $240.29 million. Novanta had a net margin of 6.52% and a return on equity of 15.20%. Novanta's quarterly revenue was up 12.5% compared to the same quarter last year. During the same quarter last year, the business earned $0.63 earnings per share. On average, equities analysts predict that Novanta Inc. will post 3.03 earnings per share for the current year.

Analyst Upgrades and Downgrades

Separately, Robert W. Baird reduced their target price on Novanta from $169.00 to $160.00 and set a "neutral" rating on the stock in a report on Monday, March 3rd.

Read Our Latest Stock Analysis on NOVT

Novanta Company Profile

(Free Report)

Novanta, Inc engages in the provision of core technology solutions to healthcare and advanced industrial original equipment manufacturers. It operates through the following segments: Photonics, Vision, and Precision Motion. The Photonics segment designs, manufactures, and markets photonics-based solutions, including laser scanning and laser beam delivery, CO2 laser, continuous wave and ultrafast laser, and optical light engine products.

Further Reading

Institutional Ownership by Quarter for Novanta (NASDAQ:NOVT)

Should You Invest $1,000 in Novanta Right Now?

Before you consider Novanta, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Novanta wasn't on the list.

While Novanta currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

5 Stocks to BUY Now as Tariff Uncertainty Fades

5 Stocks to BUY Now as Tariff Uncertainty Fades

These 5 Stocks have been beaten down by tariffs, but now that the uncertainty is fading, they're set for a rebound with all the potential downside already priced in.

Related Videos

5 Stocks to BUY Now as Tariff Uncertainty Fades

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads